Log In
Forgot username? Forgot password? New User? Sign Up Free
SCCM is performing maintenance on its websites. For the best browsing experience, please use Microsoft Edge or Safari. Those using Chrome or Firefox may experience access issues at this time.
Tag Search
Driven by a shift in how information is consumed today and a focus on environmentally friendly publishing practices, the Society of Critical Care Medicine (SCCM) is transitioning its journals Critical Care Medicine (CCM) and Pediatric Critical Care Medicine (PCCM) to fully online formats beginning January 2025. The last printed editions of the two journals will be the December 2024 issues.
The Society of Critical Care Medicine (SCCM) has named Jonathan E. Sevransky, MD, MHS, FCCM, as the new editor-in-chief of Critical Care Medicine, starting in October 2024.
From the earliest days of critical care medicine, the importance of measuring cardiac output and hemodynamic monitoring were recognized in understanding the physiology of critically ill patients. However, methods for measuring cardiac output were cumbersome or not widely available. Ashish K. Khanna, MD, FCCP, FCCM, is joined by Margaret M. Parker, MD, MCCM, to discuss the evolution of the pulmonary artery catheter in critically ill patients, as discussed in “The Story of the Pulmonary Artery Catheter: Five Decades in Critical Care Medicine,” published in Critical Care Medicine.
Bloodstream infections acquired in the ICU are potentially preventable. Listen to a discussion on the article, “Epidemiology of ICU-Onset Bloodstream Infection: Prevalence, Pathogens, and Risk Factors Among 150,948 ICU Patients at 85 U.S. Hospitals.” This podcast is sponsored by Sound Physicians.
Written communication, as a supplement to traditional verbal communication, may overcome some of the challenges that clinicians face when engaging with families in the ICU. Learn more in this discussion of the Critical Care Medicine article “Daily Written Care Summaries for Families of Critically Ill Patients: A Randomized Controlled Trial." This podcast is sponsored by Sound Physicians.
Clazakizumab is a monoclonal antibody against human interleukin-6 that may benefit patients hospitalized with severe or critical COVID-19 accompanied by hyperinflammation. Although not yet FDA approved, clinical trials are underway worldwide. Samantha Gambles Farr, MSN, NP-C, CCRN, RNFA, is joined by Bonnie E. Lonze, MD, PhD, to discuss the article, “A Randomized Double-Blinded Placebo Controlled Trial of Clazakizumab for the Treatment of COVID-19 Pneumonia With Hyperinflammation.”
Catecholamine is used in patients with septic shock to augment hemodynamics and achieve goal mean arterial pressure. Ludwig H. Lin, MD, is joined by Gretchen L. Sacha BCCCP, PharmD, to discuss this retrospective observational study to evaluate the associations of catecholamine dose, lactate concentration, and timing from shock onset at vasopressin initiation with in-hospital mortality. This podcast is sponsored by Sound Physicians.
Explore articles from the Society's leading critical care journals in this webcast series.
The latest SCCM Podcast episodes related to Critical Care Medicine.